https://www.selleckchem.com/pr....oducts/mg-101-alln.h
We demonstrate that while cases I, III and IV showed efficacies of 98-100%; cases II and V , which are the most commonly used, resulted with significantly lower efficacies of 10-24% to mitigate the dispersion of nebulization aerosols. Therefore, implementing cases I, III and IV in health care facilities may help battle the contaminations and infections via aerosol transmission during a pandemic.Background The COVID-19 incidence rates across different geographical regions (e.g., counties in a state, states in a nation, countries in a
Like
Comment
Share
